NCT05915260View on ClinicalTrials.gov

CMR in T2DM: The NSR Cohort

Enrolling by invitationOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2030

Conditions
Diabetes Mellitus, Type 2Diabetic CardiomyopathiesCardiovascular Magnetic Resonance ImagingCoronary Microvascular DysfunctionMyocardium; Fibrosis
Interventions
DIAGNOSTIC_TEST

All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion

This is a observational follow up study accordingly all subjects will undergo the same examinations

Trial Locations (1)

4200

Slagelse Hospital, department of cardiology and endocrinology, medicine 2, Slagelse

All Listed Sponsors
collaborator

Herlev Hospital

OTHER

lead

Slagelse Hospital

OTHER